Anti-SARS-CoV-2 humoral and cellular responses in multiple sclerosis patients treated with anti-CD20 monoclonal antibodies

Detalles Bibliográficos
Autores principales: Nicolas, Philippe, Marion-Moffet, Hugo, Gossez, Morgane, Vukusic, Sandra, Monneret, Guillaume, Marignier, Romain, Venet, Fabienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Letter to the Editors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9466351/
https://www.ncbi.nlm.nih.gov/pubmed/36094632
http://dx.doi.org/10.1007/s00415-022-11353-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9466351/
https://www.ncbi.nlm.nih.gov/pubmed/36094632
http://dx.doi.org/10.1007/s00415-022-11353-y

Ejemplares similares